A first-of-its-kind deal between a Massachusetts health care provider and a major American drug manufacturer could dramatically change how insurers and patients pay for medicine. It’s a money back deal involving a drug called Repatha that lowers bad cholesterol — but at a high price.
Martha Bebinger (@mbebinger) from Here & Now contributor WBUR explains how it works.
Copyright 2021 NPR. To see more, visit https://www.npr.org.